NASDAQ:ATOS

Atossa Genetics Stock Forecast

etoro logo Buy ATOS
*Your capital is at risk
$4.47
-0.380 (-7.84%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of ATOS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ATOS to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Is Atossa Genetics stock still a buy after falling -7.84% on Friday?
(Updated on Jun 05, 2026)

Sell candidate since Jun 04, 2026 Loss -7.84%

The Atossa Genetics stock price fell by -7.84% on the last day (Friday, 5th Jun 2026) from $4.85 to $4.47. During the last trading day the stock fluctuated 9.09% from a day low at $4.40 to a day high of $4.80. The price has fallen in 6 of the last 10 days and is down by -10.06% for this period. Volume has increased on the last day by 34 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 81 thousand shares were bought and sold for approximately $361.82 thousand.

Given the current horizontal trend, you can expect Atossa Genetics stock with a 90% probability to be traded between $4.48 and $6.20 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ATOS Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Atossa Genetics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.91 and $5.29. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 20, 2026, and so far it has fallen -27.55%. Further fall is indicated until a new bottom pivot has been found. Atossa Genetics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Atossa Genetics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.400 between high and low, or 9.09%. For the last week, the stock has had daily average volatility of 5.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATOS) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Atossa Genetics Inc. to open at $4.56, and during the day (based on 14 day Average True Range), to move between $4.32 and $4.62, which gives a possible trading interval of +/-$0.304 (+/-7.05%) up or down from last closing price. If Atossa Genetics Inc. takes out the full calculated possible swing range there will be an estimated 7.05% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.78, some $0.310 (6.94%) from the current price of $4.47, our system finds the risk reward not very attractive.

Is Atossa Genetics Inc. stock A Buy?

Atossa Genetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.439 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $4.56 ( 1.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ATOS Performance

Trading levels for ATOS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.96 10.89%
R2 4.80 7.47%
R1 4.71 5.36%
Price 4.47
S1 4.40 -1.48%
S2 4.31 -3.59%
S3 4.16 -7.01%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.58 24.83%
R2 5.33 19.24%
R1 4.78 6.94%
Price 4.47
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Atossa Genetics Stock and on which exchange is it traded?
The symbol for Atossa Genetics is ATOS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Atossa Genetics Stock?
Atossa Genetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Atossa Genetics Stock?
Atossa Genetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Atossa Genetics Stock.

What's the current price of Atossa Genetics Stock?
As of the end of day on the Jun 05, 2026, the price of an Atossa Genetics (ATOS) share was $4.47.

What is the 52-week high and low for Atossa Genetics Stock?
The 52-week high for Atossa Genetics Stock is $19.35 and the 52-week low is $3.80.

What is the market capitalization of Atossa Genetics Stock?
As of the Jun 05, 2026, the market capitalization of Atossa Genetics is 38.493M.

When is the next earnings date for Atossa Genetics?
The upcoming earnings date for Atossa Genetics is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT ATOSSA GENETICS INC.
Atossa Genetics
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE